|
Volumn 23, Issue 24, 2013, Pages 6610-6615
|
Pyrido[2,3-d]pyrimidines: Discovery and preliminary SAR of a novel series of DYRK1B and DYRK1A inhibitors
|
Author keywords
Anti cancer; DYRK1A; DYRK1B; Kinase inhibitor; Pyrido 2,3 d pyrimidine
|
Indexed keywords
DUAL SPECIFICITY TYROSINE REGULATED KINASE 1A;
DUAL SPECIFICITY TYROSINE REGULATED KINASE 1B;
PHENYL GROUP;
PROTEIN SERINE THREONINE KINASE;
PROTEIN SERINE THREONINE KINASE INHIBITOR;
PYRIDO[2,3 D]PYRIMIDINE DERIVATIVE;
QUINOLONE;
SMALL INTERFERING RNA;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
AREA UNDER THE CURVE;
ARTICLE;
CHIRALITY;
CRYSTAL STRUCTURE;
DATA MINING;
DISTRIBUTION VOLUME;
DOWN REGULATION;
DRUG BIOAVAILABILITY;
DRUG CLEARANCE;
DRUG CONFORMATION;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG SYNTHESIS;
ENANTIOSELECTIVITY;
ENZYME ACTIVITY;
ENZYME ASSAY;
ENZYME INHIBITION;
HUMAN;
HUMAN CELL;
IC 50;
IN VIVO STUDY;
MOLECULAR MODEL;
NONHUMAN;
POLYMERIZATION;
RAT;
SINGLE DRUG DOSE;
STRUCTURE ACTIVITY RELATION;
SUPERCRITICAL FLUID CHROMATOGRAPHY;
X RAY CRYSTALLOGRAPHY;
ANTI-CANCER;
DYRK1A;
DYRK1B;
KINASE-INHIBITOR;
PYRIDO[2,3-D]PYRIMIDINE;
ANIMALS;
BINDING SITES;
CRYSTALLOGRAPHY, X-RAY;
ENZYME ACTIVATION;
HALF-LIFE;
HUMANS;
MOLECULAR DYNAMICS SIMULATION;
PROTEIN KINASE INHIBITORS;
PROTEIN STRUCTURE, TERTIARY;
PROTEIN-SERINE-THREONINE KINASES;
PROTEIN-TYROSINE KINASES;
PYRIMIDINES;
RATS;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 84888862217
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2013.10.055 Document Type: Article |
Times cited : (46)
|
References (21)
|